Henri Roché
Impact in
- Oncology top 0.2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 121
- Cancer Treatment and Pharmacology 84
- HER2/EGFR in Cancer Research 36
- PARP inhibition in cancer therapy 15
- Colorectal Cancer Treatments and Studies 14
- Neutropenia and Cancer Infections 13
-
- Breast Cancer Treatment Studies 61
- Co-authors
- P. Fumoleau (42 shared papers)Pierre Kerbrat (32 shared papers)W. Eiermann (14 shared papers)Anthony Gonçalvès (20 shared papers)Joanne L. Blum (13 shared papers)Mario Campone (29 shared papers)Hope S. Rugo (13 shared papers)Sara A. Hurvitz (14 shared papers)
- Journals
- Journal of Clinical Oncology (49 papers)Cancer Research (16 papers)Annals of Oncology (14 papers)European Journal of Cancer (12 papers)Breast Cancer Research and Treatment (8 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Henri Roché
208 papers receiving 8.9k citations
Henri Roché's Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 5.1k
- Cancer Research 2.6k
- Dermatology 399
- Pulmonary and Respiratory Medicine 1.3k
- Genetics 401
Countries citing papers authored by Henri Roché
This map shows the geographic impact of Henri Roché's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henri Roché with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henri Roché more than expected).
Fields of papers citing papers by Henri Roché
This network shows the impact of papers produced by Henri Roché. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henri Roché. The network helps show where Henri Roché may publish in the future.
Co-authors
The 25 scholars most cited alongside Henri Roché, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 213 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation Hit paper breakdown → | 2018 | 1450 |
| 2 | 2006 | 405 | |
| 3 | 2007 | 383 | |
| 4 | 2020 | 272 | |
| 5 | 2009 | 221 | |
| 6 | Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. | 1993 | 215 |
| 7 | 2009 | 210 | |
| 8 | 2011 | 210 | |
| 9 | 1996 | 207 | |
| 10 | 2005 | 205 | |
| 11 | 2009 | 191 | |
| 12 | 2011 | 188 | |
| 13 | 1993 | 188 | |
| 14 | 1995 | 185 | |
| 15 | 2007 | 174 | |
| 16 | 2010 | 167 | |
| 17 | 2010 | 164 | |
| 18 | 2016 | 161 | |
| 19 | 2012 | 115 | |
| 20 | 2018 | 109 |
About Henri Roché
Henri Roché is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Genetics, having authored 213 papers that have together received 9.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (84 papers), Breast Cancer Treatment Studies (61 papers), HER2/EGFR in Cancer Research (36 papers), Advanced Breast Cancer Therapies (22 papers), PARP inhibition in cancer therapy (15 papers), Colorectal Cancer Treatments and Studies (14 papers), Neutropenia and Cancer Infections (13 papers) and BRCA gene mutations in cancer (11 papers). The work is most often cited by research in Oncology (5.1k citations), Cancer Research (2.6k citations), Dermatology (399 citations), Pulmonary and Respiratory Medicine (1.3k citations) and Genetics (401 citations). Henri Roché has collaborated with scholars based in France, United States and Spain. Frequent co-authors include P. Fumoleau, Pierre Kerbrat, W. Eiermann, Anthony Gonçalvès, Joanne L. Blum, Mario Campone, Hope S. Rugo, Sara A. Hurvitz, Jennifer K. Litton and Johannes Ettl. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, European Journal of Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.